Literature DB >> 1203856

The response of the local immunoglobulin system to malignant lesions of the stomach. A new diagnostic test.

M Levy, E P Petreshock, C Mandell, M Deysine, I Katzka, A H Aufses.   

Abstract

The response of the local secretory immunoglobulin system to tumor antigens was studied in 71 patients suspected of harboring a gastric malignancy. Gastric aspirates were obtained by fiberoptic endoscopy and measured on single radial immunodiffusion plates (Behring Diagnostics). Patients with malignant neoplasms of the stomach were divided into Type I and Type II lesions, based on the extent and stage of the disease. Secretory IgA titers were elevated in all patients with a Type I malignant tumor confirmed by histologic examination; mean 6.1 mg/100 (SD +/- 3.7 mg/100). This leads us to believe that the host's response to malignant cells of the gastrointestinal system is an altered and elevated secretion of IgA. Evaluation of local immunoglobulin titers may be of value when used in conjunction with other diagnostic modalities in determining the nature of gastrointestinal lesions, particularly when the lesion is not metastatic or massively involving the gastric wall.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1203856     DOI: 10.1002/cncr.2820360910

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  3 in total

1.  Immunoglobulins and secretory component in endometrium and cervix. Influence of inflammation and carcinoma.

Authors:  J Hurlimann; R Dayal; E Gloor
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1978-03-10

2.  Clinical and secretory differences in pancreatic cancer and chronic pancreatitis.

Authors:  R L Goodale; R M Condie; K Gajl-Peczalska; T Taylor; J O'Leary; T Dressel; J W Borner; M P Frick; D S Fryd
Journal:  Ann Surg       Date:  1981-08       Impact factor: 12.969

3.  Serum immunoglobulin levels A, G, M, D and TNM classification in breast cancer.

Authors:  M Munzarovà; A Trnka; A Malìr
Journal:  Br J Cancer       Date:  1977-04       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.